Caribou Biosciences, Inc.
CRBU
$1.92
$0.010.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 139.34M | 147.26M | 183.95M | 208.47M | 209.54M |
| Total Receivables | 2.98M | 2.93M | 2.78M | 2.74M | 3.25M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.91M | 1.93M | 3.06M | 3.86M | 6.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 3.39M | 2.72M | 2.26M | -- |
| Total Current Assets | 145.23M | 155.51M | 192.51M | 217.32M | 219.38M |
|
|
|||||
| Total Current Assets | 145.23M | 155.51M | 192.51M | 217.32M | 219.38M |
| Net Property, Plant & Equipment | 24.43M | 23.60M | 24.64M | 38.04M | 39.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20M | 3.78M | 3.63M | 5.04M | 5.52M |
| Total Assets | 175.37M | 194.98M | 220.90M | 273.66M | 313.31M |
|
|
|||||
| Total Accounts Payable | 5.78M | 3.80M | 3.24M | 3.87M | 2.48M |
| Total Accrued Expenses | 15.72M | 17.49M | 18.46M | 18.34M | 21.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.20M | 2.69M | 2.29M | 1.90M | 1.43M |
| Total Finance Division Other Current Liabilities | 2.71M | 4.08M | 4.90M | 4.37M | 4.81M |
| Total Other Current Liabilities | 2.71M | 4.08M | 4.90M | 4.37M | 4.81M |
| Total Current Liabilities | 25.41M | 28.06M | 28.89M | 28.49M | 30.65M |
|
|
|||||
| Total Current Liabilities | 25.41M | 28.06M | 28.89M | 28.49M | 30.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.03M | 22.78M | 23.56M | 24.32M | 25.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.75M | 2.30M | 2.32M | 3.62M | 4.65M |
| Total Liabilities | 53.19M | 53.14M | 54.77M | 56.43M | 60.36M |
|
|
|||||
| Common Stock & APIC | 718.59M | 711.78M | 708.57M | 705.44M | 701.09M |
| Retained Earnings | -596.52M | -570.03M | -542.48M | -488.38M | -448.39M |
| Treasury Stock & Other | 103.00K | 93.00K | 40.00K | 167.00K | 255.00K |
| Total Common Equity | 122.18M | 141.85M | 166.13M | 217.22M | 252.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 122.18M | 141.85M | 166.13M | 217.22M | 252.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 122.18M | 141.85M | 166.13M | 217.22M | 252.95M |
|
|
|||||